Download PDF
Thromb Haemost 2013; 109(04): 759-761
DOI: 10.1160/TH12-06-0431
Letters to the Editor
Schattauer GmbH

The role of the metabolic syndrome in patients with provoked venous thromboembolic events

Francesco Dentali
1   Department of Clinical Medicine, Insubria University, Varese, Italy
,
Matteo Nicola di Minno
2   Department of Experimental and Clinical Medicine, Federico II University, Naples, Italy
,
Monica Gianni
3   Department of Cardiology, Hospital of Tradate, Tradate, Italy
,
Giovanni di Minno
2   Department of Experimental and Clinical Medicine, Federico II University, Naples, Italy
,
Alessandro Squizzato
1   Department of Clinical Medicine, Insubria University, Varese, Italy
,
Walter Ageno
1   Department of Clinical Medicine, Insubria University, Varese, Italy
› Author Affiliations
Further Information

Publication History

Received: 26 June 2012

Accepted after major revision: 20 January 2012

Publication Date:
22 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-1173.
    CrossrefPubMedGoogle Scholar
  • 2 Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358: 1037-1052.
    CrossrefPubMedGoogle Scholar
  • 3 Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-1174.
    CrossrefPubMedGoogle Scholar
  • 4 Squizzato A, Brivio L, Appio L. et al. Novel risk factors for venous thromboembolism. Hematol Oncol Clin North Am 2010; 24: 709-716.
    CrossrefPubMedGoogle Scholar
  • 50 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2496.
    CrossrefPubMedGoogle Scholar
  • 6 Gami AS, Witt BJ, Howard DE. et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414.
    CrossrefPubMedGoogle Scholar
  • 7 Ageno W, Prandoni P, Romualdi E. et al. The metabolic syndrome and the risk of venous thrombosis. A case control study. J Thromb Haemost 2006; 04: 1914-1918.
    PubMedGoogle Scholar
  • 8 Jang MJ, Choi W, Bang SM. et al. Metabolic Syndrome Is Associated With Venous Thromboembolism in the Korean Population. Atheroscl Thromb Vasc Biol 2009; 29: 311-315.
    PubMedGoogle Scholar
  • 9 Maclure M, Willett WC. Misinterpretation and misuse of the kappa statistic. Am J Epidemiol 1987; 126: 161-169.
    CrossrefPubMedGoogle Scholar
  • 10 Higgins JP, Thompson SG, Deeks JJ. et al. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560.
    CrossrefPubMedGoogle Scholar
  • 11 Guyatt GH, Oxman AD, Kunz R. et al. GRADE Working Group. What is “quality of evidence” and why is it important to clinicians?. Br Med J 2008; 336: 995-998.
    CrossrefPubMedGoogle Scholar
  • 12 Gandhi R, Razak F, Tso P. et al. Metabolic syndrome and the incidence of symptomatic deep vein thrombosis following total knee arthroplasty. J Rheumatol 2009; 36: 2298-2301.
    CrossrefPubMedGoogle Scholar
  • 13 Ambrosetti M, Ageno W, Salerno M. et al. Metabolic syndrome as a risk factor for deep vein thrombosis after acute cardiac conditions. Thromb Res 2007; 120: 815-818.
    CrossrefPubMedGoogle Scholar
  • 14 Vaya A, Martinez-Triguero ML, Espana F. et al. The metabolic syndrome and its individual components: its association with venous thromboembolism in a Mediterranean population. Metabol Syndr Rel Dis 2011; 09: 197-201.
    PubMedGoogle Scholar
  • 15 Di Minno MN, Tufano A, Ageno W. et al. Identifying high-risk individuals for cardiovascular disease: similarities between venous arterial thrombosis in perspective A 2011 update. Intern Emerg Med 2012; 07: 9-13.
    PubMedGoogle Scholar
  • 16 Dentali F, Squizzato A, Ageno W. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost 2009; 35: 451-457.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Steffen LM, Cushman M, Peacock JM. et al. Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost 2009; 07: 746-751.
    CrossrefPubMedGoogle Scholar
  • 18 Borch KH, Braekkan SK, Mathiesen EB. et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost 2009; 07: 739-745.
    CrossrefPubMedGoogle Scholar
  • 19 Ridker PM, Danielson E, Fonseca FA. et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
    CrossrefPubMedGoogle Scholar